Advanced Enzyme Technologies has entered into definitive agreement for acquisition of 80% of the paid up share capital of Palm Techno Ventures Enzyme (PTVE), Malaysia. The agreement has been entered with PTVE and two of existing shareholders of PTVE (presently holding 60% and 40% shares of PTVE). The said acquisition is expected to be completed by end of June 2017. Upon such acquisition / investment, PTVE shall become subsidiary of the company.
Recently, the company had received board’s approval for investment in PTVE by way of subscription / purchase of shares of PTVE up to RM 200,000 (80% of the paid up share capital of PTVE).
Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1659.55 |
| Dr. Reddys Lab | 1219.60 |
| Cipla | 1233.30 |
| Zydus Lifesciences | 930.25 |
| Lupin | 2308.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: